Terms ending in 2032
Every in-force patent on Codexis, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,877,474 | GH61 Glycoside Hydrolase Protein Variants and Cofactors That Enhance GH61 Activity Grace period ended Nov 4, 2026 · lapse expected · Low confidence | Codexis, Inc. | Grace period ended Nov 4, 2026 lapse expected | Low confidence | |
| US 9,005,946 | Variant Endoglucanases and Related Polynucleotides In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,365,878 | Biocatalytic Process for Preparing Eslicarbazepine and Analogs Thereof In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,605,290 | Biocatalytic Process for Preparing Eslicarbazepine and Analogs Thereof In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 9,624,478 | Biocatalysts and Methods for the Synthesis of Substituted Lactams In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,633,640 | Biocatalysts and Methods for the Synthesis of Substituted Lactams In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 10,858,635 | Biocatalysts and Methods for the Synthesis of Substituted Lactams In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 11,597,918 | Biocatalysts and Methods for the Synthesis of Substituted Lactams In force · High confidence | Codexis, Inc. | In force | High confidence | |
| US 12,163,162 | Biocatalysts and Methods for the Synthesis of Substituted Lactams In force · Medium confidence | Codexis, Inc. | In force | Medium confidence | |
| US 8,945,903 | Cellobiohydrolase Variants In force · High confidence | Codexis, Inc. | In force | High confidence | |
| 8 more term ends in 2032 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.